Literature DB >> 6173916

Clones of human cytotoxic T lymphocytes derived from an allosensitized individual: HLA specificity and cell surface markers.

B Malissen, T Kristensen, C Goridis, M Madsen, C Mawas.   

Abstract

By planned immunization of a volunteer, two stable (greater than or equal to 6 months), specific, alloreactive cytolytic T-cell clones have been established from his peripheral blood lymphocytes. One clone reacts with all serologically defined HLA-Cw3 cells from our panel, whereas the other defines a split within the serological HLA-B40 specificity. The two cytotoxic clones are SmIg-negative, E-rosette positive, EA and EAC rosette-negative, HLA-A, -B and -C- positive, and also HLA-DR- or 'Ia like'-positive. In addition, they present very similar patterns of iodinated cell surface molecules as analysed by sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE), contrasting with that of an EBV cell line derived from the same donor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6173916     DOI: 10.1111/j.1365-3083.1981.tb00558.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

Review 1.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Allele-specific peptide ligand motifs of HLA-C molecules.

Authors:  K Falk; O Rötzschke; B Grahovac; D Schendel; S Stevanović; V Gnau; G Jung; J L Strominger; H G Rammensee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

3.  Transformation of LMTK- cells with purified HLA class I genes. II. Serologic characterization of HLA-A3 and CW3 molecules.

Authors:  F A Lemonnier; P C Dubreuil; C Layet; M Malissen; D Bourel; P Mercier; B K Jakobsen; D H Caillol; A Svejgaard; F M Kourilsky; B R Jordan
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants.

Authors:  A Zeevi; C Scheffel; K Annen; R J Duquesnoy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice.

Authors:  O Dill; F Kievits; S Koch; P Ivanyi; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 6.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

7.  In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens.

Authors:  H Spits; M Breuning; P Ivanyi; C Russo; J E de Vries
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient.

Authors:  A Nonomura; G Ohta
Journal:  Gastroenterol Jpn       Date:  1987-04

9.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Authors:  J Zemmour; P Parham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.